AzarGen Biotechnologies
Stellenbosch
About AzarGen Biotechnologies
AzarGen is a biotechnology company utilising advanced genetic engineering and synthetic biology techniques to express biopharmaceutical compounds of high value.Our focus is to use plants as bioreactors to develop a pipeline of novel and patentable compounds with special emphasis on complex therapeutic proteins. AzarGen is proving the viability of its plant-based expression platform through a lead candidate, being a recombinant human therapeutic protein. AzarGen’s product is expected to increase the survivability of premature-born infants in the developed and developing world with higher clinical efficiency and at lower cost.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2016)
- Website: azargen.com
- Phone: +27835895707
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/azargen-biotechnologies-2448887 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.